Abstract
Recently a subpopulation of T cells known as regulatory T cells (Tregs) have been identified to play important role of immunomodulation in autoimmune diseases, cancer and also in transplantation immunobiology. Tregs have been identified as biomarkers for graft function status. We have generated Tregs in vitro and also used them in kidney transplantation. We have found their efficacy in safe minimization of immunosuppression in kidney transplantation. Tregs are likely to form an integral part of cell therapy which will completely change the field of clinical transplantation. However there is a wide chasm between basic cell biologists and immunobiologists (who understand the significance of Tregs) and clinicians (who do not appreciate the bedside role of Tregs). This review article discusses the genesis of Tregs, their identification markers and their diagnostic and therapeutic role in transplantation immunobiology.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
